Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

RIGLRIGL
22 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in RIGEL PHARMACEUTICALS INC

Qube Research & Technologies Ltd holds 343,897 shares of RIGL (RIGEL PHARMACEUTICALS INC), worth $9.3M as of 2026-Q1. The position was increased (+19.3% shares). RIGL represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$9.3M

Current Shares

343,897

Total Value Change

+$9.2M

Total Shares Change

+302,459

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
343,897
+19.3%
$9.3M0.0%$33.02
33
2025-Q4
Decreased
288,269
-20.1%
$12.3M0.0%$42.83
0
2025-Q3
Increased
360,966
+110.6%
$10.2M0.0%$28.75
45
2025-Q2
Increased
171,424
+10.9%
$3.2M0.0%$19.48
29
2025-Q1
Increased
154,617
+31.1%
$2.8M0.0%$17.88
33
2024-Q4
New
117,957
-
$2M0.0%$16.47
36
2024-Q3
Exited
0
-100.0%
$00.0%$16.42
0
2024-Q2
Decreased
17,667
-80.5%
$145,2230.0%$8.22
0
2024-Q1
New
90,708
-
$134,2480.0%$14.80
31
2023-Q4
Exited
0
-100.0%
$00.0%$14.50
0
2023-Q3
Decreased
124,331
-17.6%
$134,2770.0%$10.80
0
2023-Q2
Decreased
150,812
-68.1%
$194,5470.0%$13.40
0
2023-Q1
New
473,366
-
$624,8430.0%$13.40
34
2022-Q4
Exited
0
-100.0%
$00.0%$15.00
0
2022-Q3
New
576,606
-
$680,0000.0%$12.00
34
2022-Q2
Exited
0
-100.0%
$00.0%$10.30
0
2022-Q1
Increased
112,005
+8.9%
$335,0000.0%$30.10
26
2021-Q4
Decreased
102,816
-7.8%
$272,0000.0%$26.80
0
2021-Q3
Increased
111,449
+475.3%
$405,0000.0%$36.30
38
2021-Q2
Decreased
19,373
-78.8%
$84,0000.0%$44.50
0
2021-Q1
Increased
91,185
+120.0%
$312,0000.0%$34.00
38
2020-Q4
New
41,438
-
$145,0000.0%$36.20
31

Other major holders of RIGL: BlackRock, Inc., STATE STREET CORP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used